Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Sales | 1,269 | 486 | 1,064 | -227 | 1,109 |
| Gross Profit | 1,269 | 486 | 1,064 | -227 | 1,109 |
| Operating Expenses | 73,395 | 56,459 | 34,085 | 59,041 | 48,888 |
| Operating Income | -72,126 | -55,973 | -33,021 | -59,268 | -47,779 |
| Other Income | 2,448 | 4,562 | 3,663 | 26 | 20 |
| Pre-tax Income | -69,678 | -51,411 | -29,358 | -59,242 | -47,759 |
| Income Tax | -7 | -7 | -4 | -6 | -3 |
| Net Income Continuous | -69,671 | -51,404 | -29,354 | -59,236 | -47,756 |
| Net Income | $-69,685 | $-51,418 | $-29,362 | $-59,248 | $-47,762 |
| EPS Basic Total Ops | -1.83 | -1.67 | -1.52 | -8.51 | -7.38 |
| EPS Basic Continuous Ops | -1.83 | -1.66 | -1.52 | -8.51 | -7.24 |
| EPS Diluted Total Ops | -1.83 | -1.67 | -1.52 | -8.51 | -7.38 |
| EPS Diluted Continuous Ops | -1.83 | -1.66 | -1.52 | -8.51 | -7.24 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.67 | -1.52 | -8.51 | -7.51 |
| EBITDA(a) | $-72,470 | $-56,212 | $-32,894 | $-59,138 | $-47,625 |